13F-HR filed by Deep Track Capital, LP
Deep Track Capital, LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 60 holding rows worth $2,994,349,040.
- Accession
- 0001856083-24-000001
- Filer
- CIK 1856083
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 60 entries on the cover page, a total value of $2,994,349,040 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,994,349,040 with VALUE read as dollars as filed, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INSMED INC COM PAR $.01 | 457669307 | Stock | 5,350,000 | $165,796,500 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 4,063,676 | $148,324,174 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 2,000,000 | $143,240,000 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 5,000,000 | $135,250,000 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 300,000 | $114,129,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,347,300 | $112,486,077 | dollars as filed | call |
| ALKERMES PLC | G01767105 | SHS | 4,000,000 | $110,960,000 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 5,750,000 | $104,132,500 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 7,093,214 | $99,163,132 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,000,000 | $79,590,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 3,631,728 | $79,099,036 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 11,869,297 | $76,438,273 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 7,000,000 | $68,670,000 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 2,250,000 | $68,602,500 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 7,370,000 | $66,256,300 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 2,323,456 | $64,917,361 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 3,187,415 | $63,365,810 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 1,249,068 | $63,190,350 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 3,490,506 | $63,108,348 | dollars as filed | |
| GERON CORP | 374163103 | COM | 29,583,449 | $62,421,077 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 5,473,086 | $55,442,361 | dollars as filed | |
| AMBRX BIOPHARMA INC | 641871108 | COM | 3,710,412 | $52,836,267 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 500,000 | $48,215,000 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 1,815,854 | $47,539,058 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 2,900,000 | $46,545,000 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 2,284,372 | $46,281,377 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 4,297,438 | $45,982,587 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,793,966 | $44,580,055 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 2,036,990 | $43,632,326 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,000,000 | $42,130,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 1,952,760 | $42,023,395 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 9,230,769 | $41,169,230 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 725,145 | $40,245,548 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 6,100,000 | $39,589,000 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,951,580 | $33,898,945 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P200 | ADR | 2,041,670 | $33,585,472 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 450,000 | $33,115,500 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 600,000 | $33,084,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 2,997,830 | $30,937,606 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,537,176 | $27,756,705 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,930,894 | $27,090,443 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,000,000 | $26,600,000 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 31,697,539 | $26,242,393 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 288,949 | $24,124,352 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 1,062,881 | $23,670,360 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,992,731 | $21,846,936 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 1,011,829 | $19,022,385 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 500,000 | $18,170,000 | dollars as filed | call |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 300,000 | $12,228,000 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 2,523,000 | $11,782,410 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 18,400,000 | $10,396,000 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 250,000 | $9,085,000 | dollars as filed | put |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 2,044,507 | $8,464,259 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 2,510,736 | $6,854,309 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 828,485 | $6,453,898 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 275,201 | $6,310,359 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 48,280 | $5,938,440 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 1,594,931 | $5,390,867 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 6,102,770 | $4,052,239 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 499,400 | $2,896,520 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001856083-24-000001 | this filing | 2024-02-14 | acceptance time not in the bulk data set |